The goal of the National Campaign to Control HypertensionSM (NCCHSM)is to advance the clinician's awareness of the importance of preventing, diagnosing, and treating high blood pressure and its associated conditions, including diabetes, heart failure, myocardial infarction, and kidney disease.
About The National Campaign to Control Hypertension
Show Login Box
Login

Email:

Password:

Hide Login Box

NCCHSM Mission Statement

The National Campaign to Control HypertensionSM (NCCHSM) is an educational initiative sponsored by Professional Postgraduate Services® (PPS®) for primary-care physicians, specialists, and other healthcare professionals who treat patients with hypertension. Established in 2005, the principal objective of the NCCH is to advance the clinician's awareness of the importance of preventing, diagnosing, and treating high blood pressure and its associated conditions, including diabetes, heart failure, myocardial infarction, and kidney disease. Through the NCCH, PPS delivers programs and products designed to help healthcare providers optimize management of patients with hypertension across these populations.

Through the NCCH initiative's live, interactive programs, dedicated website (www.controlhypertension.org), print materials, and other tools, clinicians are provided with educational opportunities to enhance their knowledge of hypertension and its role in global-risk assessment and reduction. By presenting the most current data via avenues that provoke evocative discussion and case-based patient perspectives—through the NCCH—PPS offers healthcare providers a thorough, balanced, and realistic curriculum that can be of immediate assistance in clinical practice.

A critical part of the NCCH educational message includes the importance of early detection of elevated diastolic and systolic readings and the immediate utilization of aggressive treatment strategies. Effective lowering of stage 1 hypertension has been shown to decrease morbidity and mortality from coronary heart disease and kidney failure as well as to prevent or delay the onset of diabetes. Both lifestyle modifications and pharmacologic therapies have proven successful in effectively lowering blood pressure and thus improving global outcomes.

PPS welcomes your feedback regarding the National Campaign to Control Hypertension. By giving us your clinical perspectives and raising issues that surface in your daily practice, you will be providing valuable information that may help us in our development of future educational programs.

NCCH Education Council Members

Faculty List

  • Benjamin J. Ansell, MD

    Associate Professor
    University of Calfironia Los Angeles
    School of Medicine
    Co-Director, University of California Los Angeles Cholesterol, Hypertension & Atherosclerosis Management Program
    Los Angeles, California

  • Jan N. Basile, MD

    Acting Manager, Primary Care Service Line
    Ralph H. Johnson VA Medical Center
    Professor of Medicine
    Division of General Internal Medicine/Geriatrics
    Medical University of South Carolina
    Charleston, South Carolina

  • Henry R. Black, MD

    Associate Vice President for Research
    Chairman
    Department of Preventive Medicine
    Rush University Medical Center
    Chicago, Illinois

  • Thomas C. Blevins, MD

    Director
    Texas Diabetes & Endicrinology
    Austin, Texas

  • Robert J. Chilton, DO

    Associate Professor of Medicine
    University of Texas Health Science Center
    San Antonio, Texas

  • Michael B. Clearfield, DO

    Associate Dean for Clinical Research
    Professor of Medicine
    University of North Texas Health Science Center
    Forth Worth, Texas

  • Jay Cohn, MD

    Professor and Director
    Rasmussen Center for Cardiovascular
    Disease Prevention
    University of Minnesota
    Minneapolis, Minnesota

  • Prakash C. Deedwania, MD

    Professor of Medicine
    University of California
    San Francisco School of Medicine
    Fresno, California

  • John M. Flack, MD, MPH

    Professor, Associate Chairman for Academic Affairs
    Department of Internal Medicine
    Director, Cardiovascular Epidemiology and Clinical Applications Program
    Wayne State University School of Medicine
    Detroit, Michigan

  • Gary S. Francis, MD

    Professor of Medicine
    Cleveland Clinic Learner College of Medicine
    Case Western Reserve University
    Head of Clinical Cardiology Section
    The Cleveland Clinic
    Cleveland, Ohio

  • Thomas D. Giles, MD

    Professor of Medicine
    Lousiana State University School of Medicine
    New Orleans, Louisiana

  • Judith Hsia, MD

    Director
    Lipid Research Clinic
    Professor of Medicine
    George Washington University
    Division of Cardiology
    Washington, District of Columbia

  • Pamela R. Kushner, MD

    Assistant Clinical Professor
    Department of Family Medicine
    University of California
    Irvine Medical Center
    Irvine, California

  • Patrick E. McBride, MD, MPH

    Professor of Medicine & Family Medicine
    Associate Dean for Students
    University of Wisconsin Medical School
    Director of Preventive Cardiology
    University of Wisconsin Hospital and Clinics
    Madison, Wisconsin

  • Thomas A. Pearson, MD, MPH, PhD

    Professor and Chair
    Senior Associate Dean for Clinical Research
    University of Rochester School of Medicine
    Rochester, New York

  • Scott D. Solomon, MD

    Director
    Noninvasive Cardiac Laboratory
    Cardiovascular Division
    Brigham and Women's Hospital
    Boston, Massachusetts

  • Robert A. Vogel, MD

    Professor of Medicine
    University of Maryland School of Medicine
    Baltimore, Maryland

  • Karol E. Watson, MD, PhD

    Assistant Professor of Medicine/Cardiology
    University of California Los Angeles
    Los Angeles, California

  • Nanette Kass Wenger, MD

    Professor of Medicine
    Department of Cardiology
    Emory University School of Medicine
    Chief of Cardiology
    Grady Memorial Hospital
    Atlanta, Georgia